Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.709
-$0.0449-5.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.26M | -8.37M | -7.86M | -7.43M | -9.36M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 565.30K | 275.70K | 158.70K | -87.10K | 323.80K |
| Change in Net Operating Assets | -3.41M | 3.85M | -775.00K | -4.21M | 155.00K |
| Cash from Operations | -9.10M | -4.24M | -8.48M | -11.73M | -8.88M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 561.90K | 0.00 | 0.00 | 415.00K | 0.00 |
| Total Debt Repaid | -186.80K | -124.50K | -124.50K | -83.00K | -222.50K |
| Issuance of Common Stock | 16.64M | 3.75M | 2.81M | -- | 27.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.02M | 3.62M | 2.68M | 332.00K | 27.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.92M | -619.40K | -5.80M | -11.39M | 18.40M |